|

Sulfasalazine Clinical Trials

4 actively recruiting trials across 1 location

Also known as: Azulfidine

Pipeline

Phase 3: 2Phase 1/2: 2

Top Sponsors

  • University of Zurich1
  • University of Nebraska1
  • Tanta University1
  • Assistance Publique - Hôpitaux de Paris1

Indications

  • Cancer3
  • Arthritis1
  • Rheumatoid Arthritis1
  • Acute Myeloid Leukemia1
  • Glioblastoma1

Other3 trials

Glutamate Inhibitors in Glioblastoma
Phase 1/2
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Phase 1/2
Sulfasalazine in Patients With Metastatic Colorectal Cancer
Phase 3

Omaha, Nebraska1 trial

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

University of Nebraska Medical Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.